Rixa Tirzepatide Review: Dose Prices, Tablets and Pharmacies

Rixa Health publishes a dose-specific compounded tirzepatide injection ladder: $280 for four weeks at 2.5 mg weekly, rising to $525 for four weeks at 15 mg weekly. It separately prices tirzepatide oral-dissolving tablets and names three pharmacy partners.¹²

Those details make a more useful comparison than one undifferentiated starting headline. The main limitations are the different evidence for tablets, the actual dispensing assignment and older FAQ language that should not be treated as current compounding authorization. We reviewed public information without an appointment or medication purchase.

Compare the injection dose you are prescribed

The pricing page lists four-week injection amounts of $280, $355, $430, $475, $495 and $525 for weekly doses of 2.5, 5, 7.5, 10, 12.5 and 15 mg respectively. It says the price includes the visit and pass-through medication cost, with medicine shipped separately by the preparing pharmacy.¹

A four-week supply is not always the same as a calendar-month bill. Ask when you reorder, whether clinical visits occur at the same interval and what happens if the dose changes before supply is used. Compare the actual prescribed dose with other platforms rather than presenting $280 as an all-dose flat price.

The disclosed dose ladder helps with budgeting, but it is not a self-directed titration plan. The prescriber should determine the appropriate schedule, formulation and instructions for the individual patient.

Tablets have a separate price and evidence question

Rixa lists 30-day tablet amounts of $225 at 3 mg, $245 at 4 mg and $270 at 5 mg, plus distinct 90-day offers. The webpage's medical-weight-loss section and pricing table contain some duplicated or inconsistent strength labels, so obtain the actual prescription and order confirmation.¹³

A tablet milligram amount cannot be compared directly with a weekly injection amount. The reviewed product information does not establish bioequivalence or a matching clinical outcome. If a needle-free formulation is being considered, ask what evidence supports it and what approved alternatives could meet the same medical need.

Do not describe tablets as an FDA-approved tirzepatide route. A familiar active-drug name does not mean that the formulation was studied in the approved injection's pivotal trials.

The pharmacy network is disclosed

The partner page names Belmar Pharma Solutions, Red Rock Pharmacy and Seven Cells Pharmacy, with location and contact details.² These are useful provider disclosures, not independent verification of accreditation or proof of the dispenser assigned to you.

Request that actual pharmacy's name and confirm it is authorized to dispense in your state. Obtain concentration, storage instructions, beyond-use date and the exact administration directions. Ask whether shipping and supplies are included for the selected prescription, and which party handles a delivery problem.

The clinical service and preparing pharmacy can bill or communicate separately. Understanding each party's role helps if a prescription is delayed, a dose changes or a label needs clarification.

Functional care and access require specifics

Rixa describes telemedicine alongside hormone and functional-health services. Its weight-loss page describes assessment, a personalized plan, delivery and continuing contact.³ Ask which services are part of your purchase rather than assuming every service in the broader menu is included.

Check state eligibility, encounter requirements and the treating clinician before paying. The site's access and response descriptions are not independently measured in this review. Nor do marketing testimonials establish a particular patient's result.

Older compounding claims need current context

Rixa's FAQ still explains compounding in terms of drug shortages. That page should not be used as a blanket current legal authorization. The homepage also includes a retatrutide label, which is not evidence of an approved treatment.⁴⁵

FDA states compounded GLP-1 medicines are not FDA-approved and recommends them only when a patient's needs cannot be met by an approved drug. It separately says retatrutide cannot be used in compounding under federal law.⁷ We do not endorse investigational adjuncts or transfer their research results to this clinic's treatment.

The general website terms do not establish a complete patient-specific prescription refund and cancellation agreement in the inspected material.⁶ Obtain that agreement, including order-processing deadlines and what happens after a clinical change, before making a longer supply purchase.

Our assessment

Rixa's price ladder and named pharmacy network provide useful purchasing facts. The tablet evidence, outdated compounding language and exact patient contract remain important qualifications. Compare a written prescription-specific quote with other provider reviews, the oral tirzepatide guide and approved Zepbound costs.

To compare how formulation choice changes the information needed for a complete quote, see CeliaRx and TellHerDoc.